The ELEGANCE registry, which is focused on historically underrepresented minorities and women, analyzed endovascular treatment ...

Conclusion: The sirolimus-eluting coronary stent is associated with less ISR than non-drug-containing stents, but further investigation is needed to determine its exact place in the treatment of ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...

The prevalence of non-communicable diseases (NCDs), such as cardiovascular ... ensure the arteries remain open throughout the ...

A non-exhaustive summary of reported cases ... There are two main types of stents: bare metal stents and drug-eluting stents. Bare metal stents are composed of different alloys (typically with ...

Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting stent placement and a month after a bare-metal stent placement. Drug-eluting stents are a newer ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first two rounds ...

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral artery disease (PAD). The data, which was presented as a ...

In patients with dissections, perforations that could not be conservatively managed, for which coronary drug-eluting stents (DES) or sacrificing the artery by embolization were the only options, now ...